10.1371/journal.pone.0153696.t004 Tat Ming Ng Tat Ming Ng Wendy X. Khong Wendy X. Khong Patrick N. A. Harris Patrick N. A. Harris Partha P. De Partha P. De Angela Chow Angela Chow Paul A. Tambyah Paul A. Tambyah David C. Lye David C. Lye A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem. Public Library of Science 2016 propensity score empiric monotherapy risk factors mortality Limited data empiric carbapenem therapy multivariate analysis CI ESBL Klebsiella pneumoniae bacteraemia 394 patients 2016-04-22 06:20:39 Dataset https://plos.figshare.com/articles/dataset/A_propensity_score_for_receiving_carbapenem_adjusted_multivariable_analysis_of_30_day_relapse_bacteraemia_for_101_patients_with_ESBL_producing_i_E_i_i_coli_i_and_i_K_i_i_pneumoniae_i_bacteraemia_receiving_either_empiric_piperacllin_tazobactam_or_carbapene/3197638 <p>A propensity score for receiving carbapenem adjusted, multivariable analysis of 30-day relapse bacteraemia for 101 patients with ESBL-producing <i>E</i>. <i>coli</i> and <i>K</i>. <i>pneumoniae</i> bacteraemia, receiving either empiric piperacllin-tazobactam or carbapenem.</p>